HDAC6 Activators

Histone Deacetylase 6 (HDAC6) stands as a critical member of the histone deacetylase family, playing a pivotal role in cellular processes through its deacetylase activity. Unlike other HDACs, HDAC6 predominantly localizes in the cytoplasm and is known for its unique substrate specificity, primarily targeting non-histone proteins such as α-tubulin and heat shock protein 90 (HSP90). The deacetylation of these substrates by HDAC6 regulates various cellular functions, including microtubule dynamics, protein trafficking, and cellular response to stress. HDAC6 activators represent a distinctive class of compounds engineered to modulate the deacetylase activity of HDAC6. Among the identified chemicals, Tubastatin A, ACY-1215 (Ricolinostat), Nexturastat A, WT161, ACY-241 (Citarinostat), Tubacin, CKD-504, ACY-1215 (Citarinostat), Tubastatin B, ACY-1215 (Ricolinostat) Free Base, NCH 51, and ACY-775 have emerged as potent activators of HDAC6. These activators exert their effects by directly inhibiting the deacetylase activity of HDAC6, leading to an elevation in the levels of acetylated cellular substrates. Tubastatin A, for instance, exhibits selectivity towards HDAC6, hindering its deacetylase function on tubulin and consequently activating HDAC6. ACY-1215 (Ricolinostat) inhibits HDAC6, inducing the accumulation of acetylated substrates and directly activating HDAC6 by interfering with its deacetylase activity. Similarly, Nexturastat A and WT161 function by directly inhibiting HDAC6, resulting in the buildup of acetylated proteins and the subsequent activation of HDAC6.